Want to see JP:4584 full AI Analyst Report?
Total Valuation
Kidswell Bio Corporation has a market cap or net worth of ¥8.09B. The enterprise value is ¥6.45K.
Market Cap¥8.09B
Enterprise Value¥6.45K
Share Statistics
Kidswell Bio Corporation has 50,589,990 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding50,589,990
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Kidswell Bio Corporation’s return on equity (ROE) is -0.25 and return on invested capital (ROIC) is -3.22%.
Return on Equity (ROE)-0.25
Return on Assets (ROA)-0.07
Return on Invested Capital (ROIC)-3.22%
Return on Capital Employed (ROCE)-0.04
Revenue Per Employee205.94M
Profits Per Employee-12.94M
Employee Count32
Asset Turnover1.08
Inventory Turnover13.32
Valuation Ratios
The current PE Ratio of Kidswell Bio Corporation is ―. Kidswell Bio Corporation’s PEG ratio is -0.02.
PE Ratio―
PS Ratio1.80
PB Ratio7.17
Price to Fair Value7.17
Price to FCF-10.68
Price to Operating Cash Flow0.00
PEG Ratio-0.02
Income Statement
In the last 12 months, Kidswell Bio Corporation had revenue of 6.59B and earned -413.99M in profits. Earnings per share was -8.48.
Revenue6.59B
Gross Profit1.75B
Operating Income-138.51M
Pretax Income-402.93M
Net Income-413.99M
EBITDA-138.26M
Earnings Per Share (EPS)-8.48
Cash Flow
In the last 12 months, operating cash flow was 0.00 and capital expenditures 0.00, giving a free cash flow of 0.00 billion.
Operating Cash Flow0.00
Free Cash Flow0.00
Free Cash Flow per Share0.00
Dividends & Yields
Kidswell Bio Corporation pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.12
52-Week Price Change-40.51%
50-Day Moving Average157.96
200-Day Moving Average203.80
Relative Strength Index (RSI)49.10
Average Volume (3m)324.67K
Important Dates
Kidswell Bio Corporation upcoming earnings date is Nov 11, 2026, TBA (Confirmed).
Last Earnings DateAug 13, 2026
Next Earnings DateNov 11, 2026
Ex-Dividend Date―
Financial Position
Kidswell Bio Corporation as a current ratio of 2.72, with Debt / Equity ratio of 134.70%
Current Ratio2.72
Quick Ratio2.55
Debt to Market Cap0.22
Net Debt to EBITDA5.39
Interest Coverage Ratio-2.82
Taxes
In the past 12 months, Kidswell Bio Corporation has paid 11.07M in taxes.
Income Tax11.07M
Effective Tax Rate-0.03
Enterprise Valuation
Kidswell Bio Corporation EV to EBITDA ratio is -80.37, with an EV/FCF ratio of -10.00.
EV to Sales1.69
EV to EBITDA-80.37
EV to Free Cash Flow-10.00
EV to Operating Cash Flow-10.17
Balance Sheet
Kidswell Bio Corporation has ¥3.23B in cash and marketable securities with ¥2.48B in debt, giving a net cash position of ¥758.53M billion.
Cash & Marketable Securities¥3.23B
Total Debt¥2.48B
Net Cash¥758.53M
Net Cash Per Share¥14.99
Tangible Book Value Per Share¥33.88
Margins
Gross margin is 25.76%, with operating margin of -2.10%, and net profit margin of -6.28%.
Gross Margin25.76%
Operating Margin-2.10%
Pretax Margin-6.11%
Net Profit Margin-6.28%
EBITDA Margin-2.10%
EBIT Margin-2.10%
Analyst Forecast
The average price target for Kidswell Bio Corporation is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast-2.86%
EPS Growth Forecast-210.09%